Are lipid-lowering drugs also antiarrhythmic drugs?

This publication has 20 references indexed in Scilit:

• Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit
  Journal of the American College of Cardiology, 2001
• Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients
  Journal of the American College of Cardiology, 2000
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
  New England Journal of Medicine, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Range of serum cholesterol values in the population developing coronary artery disease
  The American Journal of Cardiology, 1995
• Antiarrhythmics Versus Implantable Defibrillators (AVID)—Rationale, design, and methods
  The American Journal of Cardiology, 1995
• Is Relationship Between Serum Cholesterol and Risk of Premature Death From Coronary Heart Disease Continuous and Graded?
  JAMA, 1986